Clinical significance of TGF-β1, TGFR l and TGFR 2 determination in patients with myelofibrosis
- VernacularTitle:骨髓纤维化患者TGF-β1及其Ⅰ、Ⅱ型受体测定的临床意义
- Author:
Xiaoli CHEN
;
Zhanzhong SHI
;
Xiaoyun PU
;
Jun DENG
- Publication Type:Journal Article
- From:Journal of Third Military Medical University
2001;23(4):457-458
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the significance of TGF-β1, TGFRl and TGFR2 in the pathogenesis and prognosis in patients with myelofibrosis. Methods The expression of TGF-β1 and its receptors (TGFR1 and TGFR2 ) in bone marrow tissues and the level of TGF-β1 in the blood of 23 patients with myelofibrosis were detected by SABC immunocytochemistry and ELISA repectively. Results Expression of TGF-β1 and TGFR 1 was significantly higher in primary and secondary myelofibrosis patients than that of the control. No significant difference of TGFR2 expression was found between the groups of myelofibrosis and the control (P>0.05). The level of TGF-β1 in the blood of the patients with myelofibrosis was significantly higher than that of the control (P<0.01) and more obvious in secondary cases while TGF-β1 decreased nearly to the normal level when patients were in clinical remission. Conclusion TGF-β1 and it's receptors may be involved in the pathogenesis of myelofibrosis and might be of importance for the prognosis of the patients with myelofibrosis.
